| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |